Pages that link to "Q46988378"
Jump to navigation
Jump to search
The following pages link to Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study (Q46988378):
Displaying 50 items.
- Computational systems analysis of dopamine metabolism (Q21144295) (← links)
- Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders (Q26826093) (← links)
- Restoration of the Dopamine Transporter through Cell Therapy Improves Dyskinesia in a Rat Model of Parkinson's Disease (Q27314456) (← links)
- Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genes (Q28088705) (← links)
- Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers. (Q31158920) (← links)
- Imaging the nigrostriatal system to monitor disease progression and treatment-induced complications (Q33708288) (← links)
- Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models (Q33790301) (← links)
- Genetic factors and manganese-induced neurotoxicity (Q33997453) (← links)
- Dopamine transporter SLC6A3 genotype affects cortico-striatal activity of set-shifts in Parkinson's disease (Q34399250) (← links)
- Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake (Q34540567) (← links)
- Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease (Q35125001) (← links)
- Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases (Q35142854) (← links)
- Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration. (Q36011221) (← links)
- Pentoxifylline Neuroprotective Effects Are Possibly Related to Its Anti-Inflammatory and TNF-Alpha Inhibitory Properties, in the 6-OHDA Model of Parkinson's Disease (Q36154563) (← links)
- Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems (Q36992085) (← links)
- Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2 (Q37132571) (← links)
- Formation and development of Lewy pathology: a critical update (Q37587790) (← links)
- Dopaminergic function and progression of Parkinson's disease: PET findings (Q37685677) (← links)
- Parkinson's disease: mitochondrial molecular pathology, inflammation, statins, and therapeutic neuroprotective nutrition (Q37779428) (← links)
- Milestones in neuroimaging (Q37882576) (← links)
- Progress in defining the premotor phase of Parkinson's disease (Q37890601) (← links)
- Advances in imaging in Parkinson's disease. (Q37947718) (← links)
- Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts (Q37955871) (← links)
- The aging striatal dopamine function (Q37969250) (← links)
- Functional neuroimaging in Parkinson's disease (Q38088371) (← links)
- Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease (Q38099828) (← links)
- Central pharmacokinetics of levodopa: Lessons from imaging studies (Q38255967) (← links)
- Neuropathobiology of non-motor symptoms in Parkinson disease (Q38481481) (← links)
- Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia (Q38937893) (← links)
- Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies (Q41655727) (← links)
- A case of systemic lupus erythematosus which Parkinsonism was induced by tacrolimus (Q42760653) (← links)
- LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity (Q42927984) (← links)
- Levodopa and pramipexole effects on presynaptic dopamine PET markers and estimated dopamine release (Q42941857) (← links)
- A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats (Q43247253) (← links)
- Sensitivity of kinetic macro parameters to changes in dopamine synthesis, storage, and metabolism: a simulation study for [¹⁸F]FDOPA PET by a model with detailed dopamine pathway. (Q43760081) (← links)
- Noradrenergic modulation of the motor response induced by long-term levodopa administration in Parkinsonian rats. (Q45996884) (← links)
- Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration. (Q46120293) (← links)
- Reduced ventrolateral fMRI response during observation of emotional gestures related to the degree of dopaminergic impairment in Parkinson disease (Q46408000) (← links)
- Evaluation of the Parkinson's KinetiGraph in monitoring and managing Parkinson's disease (Q47557053) (← links)
- Co–transplantation of macaque autologous Schwann cells and human embryonic nerve stem cells in treatment of macaque Parkinson's disease (Q48767263) (← links)
- Sequence variants in SLC6A3, DRD2, and BDNF genes and time to levodopa-induced dyskinesias in Parkinson's disease (Q48880365) (← links)
- Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion (Q49490658) (← links)
- Patients with scans without evidence of dopaminergic deficit: a long-term follow-up study (Q50246509) (← links)
- Joint pattern analysis applied to PET DAT and VMAT2 imaging reveals new insights into Parkinson's disease induced presynaptic alterations (Q64062516) (← links)
- Multimodal dopaminergic and free-water imaging in Parkinson's disease (Q64785462) (← links)
- Neuroimaging in Parkinson's disease (Q83316032) (← links)
- Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease (Q89543267) (← links)
- Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder: a multitracer positron emission tomography study (Q91855616) (← links)
- Molecular Imaging of the Dopamine Transporter (Q92571351) (← links)
- Cardiac sympathetic innervation and vesicular storage in pure autonomic failure (Q99566885) (← links)